A detailed history of Cwm, LLC transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Cwm, LLC holds 1,223 shares of CRBU stock, worth $2,066. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,223
Previous 171 615.2%
Holding current value
$2,066
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$1.56 - $2.73 $1,641 - $2,871
1,052 Added 615.2%
1,223 $2,000
Q2 2024

Jul 09, 2024

BUY
$1.62 - $5.05 $275 - $858
170 Added 17000.0%
171 $0
Q1 2024

Apr 05, 2024

BUY
$4.82 - $8.26 $4 - $8
1 New
1 $0

Others Institutions Holding CRBU

About Caribou Biosciences, Inc.


  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $103M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.